PTGS2 and cancer: Laboratory investigations have suggested mechanisms by which COX2 inhibitors might reduce the risk of cancer (Koki and Masferrer, 2002; Khan and Lee, 2009) for a range of cancers, although animal experiments have not provided consistent support.